157P Germline BRCA1/2 (gBRCA1/2) testing patterns among oncologists (ONC) treating HER2- advanced breast cancer (ABC): Results from a multi-country real-world study

Journal article

Peer reviewed

R Mahtani, A Niyazov, K Lewis, R Wild, A Rider, B Arondekar and M.P Lux

Annals of oncology, Vol.31, pp.S72-S73

2020-05

Metrics

5 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.189 Genome Studies; 1.189.597 BRCA1
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 157P Germline BRCA1/2 (gBRCA1/2) testing patterns among oncologists (ONC) treating HER2- advanced breast cancer (ABC): Results from a multi-country real-world study
Creators: R Mahtani - Medical Oncology Department, Sylvester Cancer Center, University of Miami, Deerfield Beach, FL, USA
A Niyazov - US Oncology, Pfizer, New York, NY, USA
K Lewis - Oncology, Adelphi Real World, Cheshire, UK
R Wild - Statistics, Adelphi Real World, Cheshire, UK
A Rider - Oncology, Adelphi Real World, Cheshire, UK
B Arondekar - HEOR & Market Access, Patient & Health Impact, Pfizer Inc, Collegeville, PA, USA
M.P Lux - Kooperatives Brustzentrum Paderborn, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten; Frauen- und Kinderklinik St. Louise, Paderborn, Germany
Publication Details: Annals of oncology, Vol.31, pp.S72-S73
Publisher: Elsevier Ltd
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031597934102976